- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
5
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
5 companies
Abbott India
Market Cap: ₹595.1b
Operates as a pharmaceutical company in India.
500488
₹28,340.70
7D
1.9%
1Y
-0.4%
Sanofi India
Market Cap: ₹94.7b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹4,065.80
7D
-2.5%
1Y
-33.6%
Procter & Gamble Health
Market Cap: ₹93.3b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹5,655.30
7D
-0.4%
1Y
4.8%
RPG Life Sciences
Market Cap: ₹38.6b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,353.40
7D
1.4%
1Y
8.8%
Curis Lifesciences
Market Cap: ₹993.2m
Operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India.
CURIS
₹122.85
7D
3.9%
1Y
n/a